Green Thumb Industries Inc banner

Intrinsic Value

The intrinsic value of Green Thumb Industries Inc (GTII) under the Base Case is 8.72 CAD per share. Compared with the current market price of 9.05 CAD, the stock appears Overvalued by 4% .

The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 6% a year over the next five years, less than half its five-year pace of 16%. Net margin ends at 4.6% by 2033, below its five-year average of 5.8%.

Do our valuations actually work? See backtest results .

GTII Intrinsic Value
CA$8.72
Overvaluation 4%
Intrinsic Value
Price CA$9.05
G

GTII is cheaper than usual. Still overvalued, but less so than on 95% of days in the past 5 years.

Monitor GTII
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value CA$6.98
Get notified when the price drops into your buy zone
Current Price CA$9.05
Intrinsic Value CA$8.72
Margin of Safety 20% CA$6.98
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to GTII

Fundamental Analysis

What Green Thumb Industries Does

Pharmaceuticals Health Care

Green Thumb Industries grows, processes, and sells cannabis products in the United States. It makes branded products such as flower, pre-rolls, vapes, edibles, and concentrates, and it also runs retail dispensaries where customers buy those products directly. The company serves both adult-use and medical cannabis customers, depending on the rules in each state where it operates.

Headquarters
Canada CA
Employees
4 800
IPO date
Feb 6, 1987
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Green Thumb Industries Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one GTII stock?

The intrinsic value for Green Thumb Industries Inc (GTII) under the Base Case is 8.72 CAD.

Is GTII stock undervalued or overvalued?

Compared with the current market price of 9.05 CAD, the stock appears Overvalued by 4% .

Back to Top